- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/00 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patent holdings for IPC class C07D 231/00
Total number of patents in this class: 160
10-year publication summary
|
11
|
6
|
5
|
8
|
7
|
8
|
5
|
4
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Wella Operations US LLC | 830 |
7 |
| The Johns Hopkins University | 5667 |
6 |
| Novartis AG | 10849 |
5 |
| Boehringer Ingelheim International GmbH | 4650 |
4 |
| Merck Sharp & Dohme LLC | 3748 |
4 |
| Bristol-myers Squibb Company | 4898 |
3 |
| Merck Sharp & Dohme Corp. | 2194 |
3 |
| Janssen Pharmaceutica N.V. | 3392 |
3 |
| Cardioxyl Pharmaceuticals, Inc. | 49 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 823 |
3 |
| The Wistar Institute of Anatomy and Biology | 450 |
3 |
| Hoffmann-La Roche Inc. | 3418 |
2 |
| Novartis Pharma AG | 96 |
2 |
| BASF SE | 20933 |
2 |
| Merck & Co., Inc. | 331 |
2 |
| Pfizer Inc. | 3387 |
2 |
| Bayer Intellectual Property GmbH | 2499 |
2 |
| Bayer Cropscience AG | 2035 |
2 |
| Bayer Animal Health GmbH | 221 |
2 |
| Mayo Foundation for Medical Education and Research | 3206 |
2 |
| Other owners | 98 |